Literature DB >> 3593337

Isolated tumoral pyruvate dehydrogenase can synthesize acetoin which inhibits pyruvate oxidation as well as other aldehydes.

L G Baggetto, A L Lehninger.   

Abstract

Oxidation of 1 mM pyruvate by Ehrlich and AS30-D tumor mitochondria is inhibited by acetoin, an unusual and important metabolite of pyruvate utilization by cancer cells, by acetaldehyde, methylglyoxal and excess pyruvate. The respiratory inhibition is reversed by other substrates added to pyruvate and also by 0.5 mM ATP. Kinetic properties of pyruvate dehydrogenase complex isolated from these tumor mitochondria have been studied. This complex appears to be able to synthesize acetoin from acetaldehyde plus pyruvate and is competitively inhibited by acetoin. The role of a new regulatory pattern for tumoral pyruvate dehydrogenase is presented.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3593337     DOI: 10.1016/0006-291x(87)91300-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

2.  Cloning and expression of an alpha-acetolactate decarboxylase gene from Streptococcus lactis subsp. diacetylactis in Escherichia coli.

Authors:  D Goelling; U Stahl
Journal:  Appl Environ Microbiol       Date:  1988-07       Impact factor: 4.792

3.  Specific inhibition by synthetic analogs of pyruvate reveals that the pyruvate dehydrogenase reaction is essential for metabolism and viability of glioblastoma cells.

Authors:  Victoria I Bunik; Artem Artiukhov; Alexey Kazantsev; Renata Goncalves; Danilo Daloso; Henry Oppermann; Elena Kulakovskaya; Nikolay Lukashev; Alisdair Fernie; Martin Brand; Frank Gaunitz
Journal:  Oncotarget       Date:  2015-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.